BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ, Portincasa P. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? Int J Mol Sci 2021;22:5375. [PMID: 34065331 DOI: 10.3390/ijms22105375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bellini MI, Urciuoli I, Del Gaudio G, Polti G, Iannetti G, Gangitano E, Lori E, Lubrano C, Cantisani V, Sorrenti S, D’Andrea V. Nonalcoholic fatty liver disease and diabetes. World J Diabetes 2022; 13(9): 668-682 [DOI: 10.4239/wjd.v13.i9.668] [Reference Citation Analysis]
2 Zeng C, Chen M. Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis. Biomolecules 2022;12:1079. [PMID: 36008973 DOI: 10.3390/biom12081079] [Reference Citation Analysis]
3 Ramanathan R, Ali AH, Ibdah JA. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. IJMS 2022;23:7280. [DOI: 10.3390/ijms23137280] [Reference Citation Analysis]
4 Mahmoudi A, Moallem SA, Johnston TP, Sahebkar A. Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. PPAR Res 2022;2022:5805398. [PMID: 35754743 DOI: 10.1155/2022/5805398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang J, Li T, Li M, Shi D, Tan X, Qiu F. Lycopene attenuates D-galactose-induced insulin signaling impairment by enhancing mitochondrial function and suppressing the oxidative stress/inflammatory response in mouse kidneys and livers. Food Funct 2022. [PMID: 35762205 DOI: 10.1039/d2fo00706a] [Reference Citation Analysis]
6 Nascè A, Gariani K, Jornayvaz FR, Szanto I. NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants (Basel) 2022;11:1131. [PMID: 35740032 DOI: 10.3390/antiox11061131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baj J, Forma A, Dudek I, Chilimoniuk Z, Dobosz M, Dobrzyński M, Teresiński G, Buszewicz G, Flieger J, Portincasa P. The Involvement of Human Papilloma Virus in Gastrointestinal Cancers. Cancers (Basel) 2022;14:2607. [PMID: 35681587 DOI: 10.3390/cancers14112607] [Reference Citation Analysis]
8 Catalán V, Avilés-olmos I, Rodríguez A, Becerril S, Fernández-formoso JA, Kiortsis D, Portincasa P, Gómez-ambrosi J, Frühbeck G. Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic. Nutrients 2022;14:1597. [DOI: 10.3390/nu14081597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
9 Choi SE, Hwang Y, Lee SJ, Jung H, Shin TH, Son Y, Park S, Han SJ, Kim HJ, Lee KW, Lee G, Kemper JK, Song HK, Kang Y. Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice. J Hepatol 2022:S0168-8278(22)00226-4. [PMID: 35421426 DOI: 10.1016/j.jhep.2022.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rosa-caldwell ME, Poole KE, Seija A, Harris MP, Greene NP, Wooten JS. Exercise during weight-loss improves hepatic mitophagy. Sports Medicine and Health Science 2022. [DOI: 10.1016/j.smhs.2022.04.003] [Reference Citation Analysis]
11 Du S, Zhu X, Zhou N, Zheng W, Zhou W, Li X. Curcumin alleviates hepatic steatosis by improving mitochondrial function in postnatal overfed rats and fatty L02 cells through the SIRT3 pathway. Food Funct 2022. [PMID: 35113098 DOI: 10.1039/d1fo03752h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Xu J, Shen J, Yuan R, Jia B, Zhang Y, Wang S, Zhang Y, Liu M, Wang T. Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease. Front Pharmacol 2021;12:796207. [PMID: 35002729 DOI: 10.3389/fphar.2021.796207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]
15 Pelechá M, Villanueva-bádenas E, Timor-lópez E, Donato MT, Tolosa L. Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models. Antioxidants 2022;11:86. [DOI: 10.3390/antiox11010086] [Reference Citation Analysis]
16 Didenko VI, Klenina IA, Tatarchuk ОM, Hrabovska OI, Petishko OP. Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases. Regul Mech Biosyst 2022;13:3-9. [DOI: 10.15421/022201] [Reference Citation Analysis]
17 Passarella S, Schurr A, Portincasa P. Mitochondrial Transport in Glycolysis and Gluconeogenesis: Achievements and Perspectives. Int J Mol Sci 2021;22:12620. [PMID: 34884425 DOI: 10.3390/ijms222312620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Sarkar S, Kumari D, Gupta SK, Sharma V, Mukhi S, Kamboj P, Sasibhushan V, Rai RK, Jatavallabhula SL, Mahajan D, Kumar Y, Kumar A, Dikshit M. Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. Biomed Pharmacother 2021;144:112357. [PMID: 34794234 DOI: 10.1016/j.biopha.2021.112357] [Reference Citation Analysis]
19 Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. Int J Mol Sci 2021;22:7702. [PMID: 34299321 DOI: 10.3390/ijms22147702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]